Too long and excruciatingly boring to read. But what I take out of it is the research involved crossing a Botrytis-susceptible domestic tomato plant (of Lycopersicon esculentum) with a Botrytis-resistant wild tomato plant (of Lycopersicon hirsutum), and then selected from among the prodigy for Botrytis-resistant offspring. "(8. The method according to claim 4, wherein said transfer of nucleic acid comprises the steps of: crossing said Botrytis-resistant donor tomato plant with a Botrytis-susceptible recipient tomato plant to produce offspring plants; and selecting a plant that comprises in its genome said at least one QTL.)"
The same thing is done many times in many breeding programs (not just by Monsanto companies) since all the modern disease resistances are taken from wild tomato species and bred into domestic lines. This type of breeding represents a valuable improvement of domestic tomato lines, and therefore the breeders feel warranted in patenting the results to protect their investment.
|